A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus |
| |
| Authors: | Furie Richard,Petri Michelle,Zamani Omid,Cervera Ricard,Wallace Daniel J,Tegzová Dana,Sanchez-Guerrero Jorge,Schwarting Andreas,Merrill Joan T,Chatham W Winn,Stohl William,Ginzler Ellen M,Hough Douglas R,Zhong Z John,Freimuth William,van Vollenhoven Ronald F BLISS- Study Group |
| |
| Affiliation: | Division of Rheumatology and Allergy–Clinical Immunology, North Shore-Long Island Jewish Health System, Lake Success, New York 11042, USA. furie@nshs.edu |
| |
| Abstract: | ![]()
|
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
